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Abstract: 12 
The bioavailability of buserelin acetate when added to the seminal dose appears 13 
to be determined by the activity of the existing aminopeptidases. Thus, the addition of 14 
aminopeptidase inhibitors to rabbit semen extenders could be a solution to decrease the 15 
hormone degradation. This study was conducted to evaluate the effect of the protease 16 
activity inhibition on rabbit semen quality parameters and reproductive performance 17 
after artificial insemination. Seminal quality was not affected by the incubation with 18 
protease inhibitors, being the values of motility, viability and acrosome integrity not 19 
significantly different between the protease inhibitors and the control group. In addition, 20 
seminal plasma aminopeptidase activity was inhibited in a 55.1% by the protease 21 
inhibitors. On the other hand, regarding the effect of protease inhibitors on reproductive 22 
performance, our results showed that the presence of protease inhibitors affected the 23 
prolificacy rate (9.2±0.26 and 9.3± 0.23 vs 8.2 ± 0.22 total born per litter for negative 24 




having this group one kit less per delivery. We conclude that the addition of a wide 26 
variety of protease inhibitors in the rabbit semen extender negatively affects prolificacy 27 
rate. Therefore, the development of new extenders with specific aminopeptidase 28 
inhibitors would be one of the strategies to increase the bioavailability of GnRH 29 
analogues without affecting the litter size.   30 
 31 
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 34 
1. Introduction 35 
The addition of the GnRH synthetic analogues to the seminal dose is a welfare-36 
orientated method to induce ovulation in rabbits and in addition reduces the time spent 37 
by farmers [1]. The success of this method depends on the enzymes present in the 38 
seminal plasma [2], the status of the vaginal mucosa and on the extender composition 39 
[3]. Consequently, to achieve similar fertility results, when the GnRH analogue is 40 
applied intravaginally, the required concentration is much higher than the one used 41 
intramuscularly. Results from Vicente et al. [4] showed that when buserelin acetate 42 
was added to seminal plasma diluted 1:5, a more marked decrease in ovulation 43 
frequency occurred than if it was diluted 1:20. This was due to the increased 44 
availability of GnRH analogue as a consequence of the reduction of the existing 45 
aminopeptidases.  Recently, Viudes de Castro et al. [2] showed that the bioavailability 46 
of buserelin acetate when added to the seminal dose appears to be determined by the 47 
activity of the existing seminal plasma aminopeptidases. In addition, it has been 48 
observed that males selected for maternal characteristics showed significantly lower 49 




origin of rabbit male could determine the aminopeptidase concentration present in the 51 
seminal plasma [5]. These facts suggest that a possible solution to avoid using high 52 
hormone levels to induce ovulation effectively in rabbit could be the addition of 53 
aminopeptidase inhibitors to semen extenders. This way, part of the enzyme activity 54 
that degrades the GnRH analogue would be inhibited and therefore, the bioavailability 55 
of the hormone would be higher.  56 
The aim of this study was to evaluate the effect of the inclusion of protease 57 
inhibitors in semen extender on in vitro rabbit semen quality parameters (motility, 58 
viability and acrosome status) and in vivo reproductive performance (fertility and 59 
prolificacy) after artificial insemination.  60 
 61 
2. Materials and Methods 62 
Unless stated otherwise, all chemicals in this study were purchased from Sigma-63 
Aldrich Química S.A (Madrid, Spain). 64 
 65 
2.1. Animals 66 
All animals were handled according to the principles of animal care published 67 
by Spanish Royal Decree 53/2013.  68 
To study the effect of protease inhibitors on semen quality parameters, a total of 69 
12 adult bucks belonging to a paternal rabbit line (Line R) were used. All males were 70 
kept individually in flat deck cages under 16 h light/8 h dark conditions at the 71 
experimental farm of the Animal Technology and Research Centre (CITA-IVIA, 72 
Segorbe, Castellón, Spain) and fed ad libitum with the same commercial diet (17.5% 73 
crude protein, 2.3% ether extract, 16.8% crude fiber, 2.600 kcal DE/Kg) and had free 74 




To study the effect of protease inhibitors on reproductive performance, 76 
commercial crossbreed does were inseminated on one commercial farm (Altura, 77 
Castellón, Spain) with semen from the 12 Line R adult males. A total of 709 artificial 78 
inseminations were performed. Receptive females were classified by physiological 79 
status as multiparous lactating does (more than two delivered births and eight or nine 80 
young rabbits suckled), multiparous non-lactating females (females with more than one 81 
delivery without suckling any young) and nulliparous females (females who have never 82 
given birth). Multiparous lactating does were inseminated 10 to 12 days after delivery. 83 
The sexual receptivity in multiparous does was obtained by closing the nest during 36 h. 84 
 85 
2.2. In vitro effect of protease inhibitors on seminal quality 86 
 87 
2.2.1. Semen collection and evaluation 88 
 Two ejaculates per male were collected each week during 4 weeks using an 89 
artificial vagina, with a minimum of 30 minutes between ejaculate collections, on a 90 
single day. Sperm evaluation was performed to assess the initial seminal quality. Only 91 
ejaculates exhibiting a white colour and possessing motility rate higher than 70% were 92 
used in the experiment. Finally, the ejaculates were pooled. In total, four pools were 93 
used.   94 
In order to evaluate seminal quality aliquots of pooled semen were taken. A 20 95 
µl aliquot was diluted 1:50 with 0.25% glutaraldehyde solution to calculate the 96 
concentration and rate of abnormal sperm in a Thoma chamber by phase contrast at a 97 
magnification of 400X.  98 
The motility characteristics of sperm (percentage of total and progressively 99 




determined as described by Viudes de Castro et al [2]. A spermatozoon was defined as 101 
non-motile if the average path velocity (VAP) was <10 m s
-1
 and a spermatozoon was 102 
considered to be progressively motile when VAP was >50 m s
-1
 and the straightness 103 
index (STR) was ≥70%. 104 
Flow cytometric analyses to assess viability and acrosome integrity, were 105 
performed using a Coulter Epics XL cytometer (Beckman Coulter, IZASA, Barcelona, 106 
Spain). The fluorophores were excited by a 15 mW argon ion laser operating at 488 nm. 107 
A total of 10,000 gated events (based on the forward scatter and side scatter of the 108 
sperm population recorded in the linear mode) were collected per sample. Flow 109 
cytometric data were analyzed with the software Expo32ADC (Beckman Coulter Inc.). 110 
Samples were diluted to 30 x 10
6
 sperm/mL with TCG extender [6] supplemented with 111 
2g/L BSA. All the dilutions were performed at 22 ºC.  The percentage of viable sperm 112 
was determined using a dual fluorescent staining with SYBR-14/PI according to 113 
Viudes-de-Castro et al. [2]. The status of the acrosome in each sample was determined 114 
using a dual fluorescent staining with FITC-PNA/PI. Diluted samples were stained by 115 
transferring 0.1 mL aliquots into tubes containing 0.45 mL of TCG, 1.5 µl of 116 
fluorescein labeled lectin from the peanut plant Arachis hypogaea (FITC-PNA, 1 117 
mg/mL solution in saline solution) and 2.5 µL of PI (1.5 mM solution in purified water). 118 
They were incubated (10 minutes, 22ºC), filtered through a 40-µm nylon mesh to 119 
remove large clumps of cells and debris. Fluorescence was measured using a FL-1 120 
sensor, a 525 nm band-pass filter to detect FITC-PNA, and a FL-2 sensor and a 575 nm 121 
band-pass filter to detect PI. Four sperm sub-populations were detected: live acrosome 122 
intact, live acrosome damaged, dead acrosome intact and dead acrosome damaged. 123 
Percentage of normal apical ridge (NAR) was calculated as the proportion of acrosome 124 





2.2.2. Protease inhibitor activity evaluation 127 
 In this experiment, two different extenders were tested: TCG (control) and an 128 
experimental extender containing TCG supplemented with Protease Inhibitor Cocktail 129 
(P2714, Sigma) diluted 1:100. The protease inhibitor cocktail used contains 4-(2-130 
Aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF), aprotinin,  bestatin, E-131 
64, Ethylenediaminetetraacetic acid (EDTA) and leupeptin. Sperm samples were split 132 
into two equal fractions and diluted 1:20 with TCG (control) and supplemented TCG  133 
respectively. Fractions were stored two hours at room temperature (20-25°C). Then, 134 
three aliquots of each sample were taken to measure the motility, the viability and the 135 
status of the acrosome again. The remaining pooled semen was used to measure alanyl 136 
peptidase (APN) activity. 137 
 138 
2.2.3. Seminal plasma preparation and measurement of APN activity 139 
Semen samples were centrifuged at 10.000x g for 10 min at 22 ºC. The resulting 140 
supernatants were collected and centrifuged again (10.000x g for 10 min) to remove 141 
residual spermatozoa and cell debris. The resulting pellets were discarded, whereas the 142 
supernatants were stored at -80ºC until use. 143 
APN activity in seminal plasma was determined according to Viudes-de-Castro 144 
et al. [2]. Briefly, samples were incubated with the substrate (alanine-β-naphthylamide) 145 
for 30 min at 37 ° C, after which the reaction was stopped with 0.1 M sodium acetate 146 
buffer (pH 4.2). The released of β-naphthylamide as a result of enzyme activity was 147 
determined by measuring the fluorescence intensity at 460 nm with excitation at 355 148 
nm. Protein concentration of semen samples was measured using the bicinchoninic acid 149 
(BCA) method, using BSA as the standard [7]. APN activity and protein concentration 150 




naphthylamide released per milligram of protein per minute. In order to calculate the 152 
percentage of APN activity inhibition, the APN activity of the control group was used 153 
as reference in each case. 154 
 155 
2.3. In vivo effect of protease inhibitors on reproductive performance 156 
 157 
2.3.1. Semen collection and evaluation 158 
 Each week, two ejaculates per male were collected, with a minimum of 30 159 
minutes between ejaculate collections, on a single day using an artificial vagina. Sperm 160 
evaluation was performed to assess the initial seminal quality. Only ejaculates 161 
exhibiting a white colour and possessing more than 70% of motility rate, 85% of normal 162 
intact acrosome, and less than 15% of abnormal sperm were used in this experiment. All 163 
other ejaculates were discarded. The pools used in the experiment presented an average 164 
sperm concentration of 296 spermatozoa mL
-1
. 165 
The remaining pooled semen was split into three aliquots and diluted 1:20 166 
respectively with 1) TCG extender supplemented with 10 µg of buserelin acetate/mL 2) 167 
TCG extender supplemented with the protease inhibitor (protease inhibitor cocktail 168 
dilution rate 1:100) and 10 µg of buserelin acetate/mL and 3) TCG extender (non 169 
GnRH-supplemented). 170 
 171 
2.3.2. Insemination procedure 172 
A total of 709 inseminations were performed in six different days. Only 173 
receptive females (red colour of vulvar lips) were inseminated with 0.5 ml of semen 174 
using standard curved pipettes (22 cm). Each female was randomly assigned to one of 175 




-Positive control group: does inseminated with 0.5 mL diluted semen in TCG. At the 177 
time of insemination, each female received an intramuscular injection of buserelin 178 
acetate to induce ovulation (1 µg per doe). 179 
-Negative control group: does inseminated with 0.5 mL diluted semen in supplemented 180 
extender with 10 g/mL of buserelin acetate. 181 
-Protease inhibitors group: does inseminated with 0.5 mL diluted semen in 182 
supplemented extender with protease inhibitor cocktail (dilution rate 1:100) and 10 183 
g/mL of buserelin acetate.  184 
Fertility rate at birth (number of does giving birth/number of inseminated does) and 185 
prolificacy (number of total kits born) were reproductive performances considered. 186 
 187 
2.4. Statistical analysis 188 
Data were statistically evaluated with SPSS 16.0 library procedures (SPSS Inc., 189 
Chicago, Illinois, USA, 2002). To analyse the effect of the extender on motility, 190 
viability and acrosome integrity, an analysis of variance (ANOVA) was used. A probit 191 
link with binomial error distribution was used to analyse the fertility rate at birth, 192 
including as fixed effects the extender used and the physiological state of the females 193 
and their interactions. For total number of kits born per litter, a general linear model 194 
procedure (GLM) was performed, including as fixed effects the extender used and the 195 
physiological state of the females and their interactions. Means were separated using 196 
Fishers Least Significant Difference (LSD) test at a fixed 5% error level and the results 197 
are presented as least square means values (LSM) ± standard error of the mean (SE).  198 
 199 
3. Results  200 




 Results showed that the presence of protease inhibitors did not affect the 202 
motility, neither the viability nor the acrosome integrity of the seminal samples. The 203 
percentage of total motile sperm, percentage of progressively motile sperm, average of 204 
curvilinear velocity (VCL), mean amplitude of lateral head displacement (ALH), 205 
frequency of head displacement (BCF), linearity coefficient (LIN) and VAP were 206 
90.4±2.1%, 50.4±5.8%, 52.06±4.18m/s, 2.42±0.1010.0±0.2848.71±2.14% and 207 
35.52±3.35m/s respectively (data not shown in tables). The values of viability and 208 
acrosome integrity after two hours of incubation with the two extenders were similar 209 
(82.5±2.03 of viability and 98.7±0.4 % of normal apical ridge). On the other hand, the 210 
APN activity was inhibited in the extender containing the protease inhibitors cocktail. 211 
The APN activity was a 55.1% lower than the control extender.  212 
 213 
3.2. Effect of protease inhibitors in fertility and prolificacy 214 
Fertility rate at birth and prolificacy are presented in Table 1. These parameters 215 
were affected by the experimental group. Positive control group showed the highest 216 
fertility rate at birth while the fertility of females from groups with buserelin acetate in 217 
the seminal dose was reduced 19 and 15% (negative control group and protease 218 
inhibitors group, respectively).   219 
Regarding prolificacy, the total number of kits born per litter was affected by 220 
treatment (P<0.05; Table 1). Does from the positive and the negative control group 221 
showed similar prolificacy rate. On the other hand, females from protease inhibitors 222 
group showed a significantly lower prolificacy than the other two groups. 223 
Multiparous non-lactating and nulliparous does showed significantly higher 224 
fertility rate than the multiparous lactating does group (0.77 ±0.02 and 0.79 ± 0.07 vs. 225 




No interaction between experimental group and physiological status at the 227 
moment of insemination was observed. 228 
 229 
Table 1 230 
Reproductive performance of does inseminated. (Least square means ± standard error). 231 
Groups Inseminated does Fertility rate at birth Total Born per litter 




Negative control 273 0.65 ± 0.04
b
 9.3 ± 0.23
a 
Protease inhibitors 269 0.69 ± 0.04
b
 8.2 ± 0.22
b 
Positive control: does induced to ovulate with buserelin acetate applied intramuscularly, 232 
Negative control: does induced to ovulate with buserelin acetate added in the insemination 233 
extender; Protease inhibitors: does induced to ovulate with buserelin acetate added in the 234 
insemination extender containing protease inhibitors. 235 
Values within a column with different superscripts in the same column differ 236 
significantly at P<0.05. 237 
 238 
4. Discussion 239 
In this paper, we have shown that rabbit semen extender does not affect semen 240 
quality nor fertility rate, but affects the prolificacy rate by decreasing the total number 241 
of kits born per litter.  242 
In mammals, seminal plasma is a complex mixture of secretions from the 243 
epididymis and from the various accessory sex glands [8]. Its composition is designed 244 
to assure the successful fertilization of the oocyte and is characterized by a high 245 
abundance of proteins which play important roles in sperm survival and are involved in 246 
various events such as epididymal sperm maturation, sperm capacitation, sperm 247 
membrane stabilization, modulation of the uterine immune response, sperm transport in 248 
the female genital tract, gamete interaction and fusion and even pregnancy 249 
establishment [9,13]. In human, the 60% of the seminal plasma proteome has enzymatic 250 




importance of this system in this body fluid [14]. Many enzymes, hormones and other 252 
physiologically active proteins are synthesized as inactive precursors that are converted 253 
to the active form by the action of specific proteases. 254 
Since the protease inhibitor cocktail tested in this work contained a broad 255 
enzyme inhibition spectrum it was predictable that the seminal quality, the fertilization 256 
process, or both, were affected. 257 
Several studies have tested the effect of different protease inhibitors on mammal 258 
sperm in vitro quality and fertilization process. For instance, leupeptin had no effect in 259 
rabbit sperm motility [15]. In pig, spermatozoa incubated in medium with AEBSF were 260 
less motile after 6 h of incubation, yet progressive motility, VAP, VSL, acrosome status 261 
and mitochondrial potential remained unaltered [16]. These results are consistent with 262 
ours, since seminal quality parameters were similar between control and protease 263 
inhibitors group after 2 h of incubation. 264 
In the present work, the inclusion of protease inhibitors in semen extender 265 
affected only the prolificacy rate, having this group one kit less per delivery. This fact 266 
could be explained because proteases play an important role during mammalian 267 
fertilization, so the inhibition of a wide variety of proteases in this work, could have 268 
negatively affected this process. The part of the fecundation process affected by  269 
protease inhibitors seems to be species-specific. In guinea pig, the incubation of sperm 270 
with leupeptin inhibited the completion of the acrosomal reaction, but bestatin had no 271 
effect [17]. In bovine sperm, the use of trypsin and chymotrypsin inhibitors, but not 272 
metalloproteases, were effective in inhibiting the acrosomal reaction process and in 273 
addition, sperm incubation with these proteases did not reveal statistically differences in 274 
the sperm zona pellucida binding capacity in relation to control sperm [18]. In pig, the 275 




least 50% [16]. In mouse and human, the use of specific serine proteases inhibitors 277 
decreases the fertilization rate [19,20]. Finally, studies in sea urchin provide evidence 278 
for the involvement of metalloproteases in membrane fusion during the acrosome 279 
reaction [21]. 280 
Considering the results of the present study, we can conclude that the addition of 281 
a wide variety of protease inhibitors in the rabbit semen extender negatively affects the 282 
prolificacy rate. Therefore, the development of new extenders with specific 283 
aminopeptidase inhibitors would be one of the strategies to increase the bioavailability 284 
of GnRH analogues without affecting the litter size. In the future, the study of inhibitors 285 
individually will be necessary to define how to increase the GnRH bioavailability 286 
without affecting the fertilizing capacity of spermatozoa. 287 
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